Prostate Cancer VL

Improving Survival in Advanced Prostate Cancer: The Changing Role of the Urologist

Details
Improving Survival in Advanced Prostate Cancer: The Changing Role of the Urologist - Firmagon Session E. David Crawford, MD

Overdiagnosis and Overtreatment of Cancer

Details
Commentary on JAMA Article, "Overdiagnosis and Overtreatment in Cancer," by Dr. Ian M. Thompson, Jr. Dr. Ian M. Thompson, Jr. comments on the recently published article "Overdiagnosis and Overtreatment in Cancer – An Opportunity for Improvement" in the Journal of the American Medical Association from July 29, 2013. Dr. Thompson Jr. - BIO

Current Evidence on Androgen Resistance

Details
Clinical Approaches to Androgen Resistance Charles Ryan, MD provides the current evidence on androgen resistance including why we understand that 1) not all resistance is the same, 2) tumor collection is a reality, and 3) there are rational approaches to combination and sequencing strategies. CHARLES RYAN, MD.

PCPT Long-term Survival - Commentary

Details
Commentary on "Long-term Survival of Participants in the Prostate Cancer Prevention Trial" Dr. Thomas E. Keane provides his thoughts on the article published in the August 15, 2013 issue of the New England Journal of Medicine regarding the Prostate Cancer Prevention Trial (PCPT). Click HERE to read the abstract

PCPT Long-term Survival Update

Details
Prevention of Prostate Cancer – Long-term Survival of Participants of the PCPT Dr. Ian Thompson, Jr. discusses the most recent update of the Prostate Cancer Prevention Trial (PCPT) published in the New England Journal of Medicine on August 15, 2013. Click HERE to read the abstract